Navigation Links
ViroPharma To Participate In Several June Healthcare Investor Conferences
Date:5/31/2013

EXTON, Pa., May 31, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano , president and chief executive officer of ViroPharma, will present at the Jefferies 2013 Healthcare Conference at 9:30 AM ET on Wednesday June 5, 2013.  The conference is being held in New York City.

ViroPharma also announced that Charles Rowland , vice president and chief financial officer of ViroPharma, will present at the Goldman Sachs 34th Annual Global Healthcare Conference at 4:00 PM PT (7:00 PM ET) on Tuesday, June 11, 2013.  The conference is being held in Rancho Palos Verdes, CA.

Mr. Milano also will be presenting at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 2:20 PM ET on Tuesday, June 18, 2013.  The conference is being held in Boston, MA.

ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated
ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options. ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, cytomegalovirus (CMV), Friedreich's Ataxia, eosinophilic esophagitis (EoE) and adrenal insufficiency. Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures in children and adolescents, adrenal insufficiency and C. difficile-associated diarrhea (CDAD). For full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma er stolt over at bakke op om HAE-dag :-) 2013 og vi hjælper HAE-patienter med at fylde verden med smil
2. ViroPharma To Release 2013 First Quarter Financial Results On May 1, 2013
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
4. ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences
5. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
6. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
7. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
8. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
10. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
11. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the ... of a moisturizer with the power of an anti-aging concentrate. , ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, Christine Collins of ... Year for her extraordinary compassion and lifelong dedication to serve others. Since 1997, ... for the prestigious award each year – identifying a CAREGiver who has exemplified ...
(Date:4/27/2017)... ... ... Plastic Surgery Associates is excited to announce that Heather Furnas, MD, and ... Meeting. Held in San Diego, at the San Diego Convention Center, the annual event ... to the Premier Global Hot Topics session, speaking on genital rejuvenation. , Hosted by ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs today is releasing ... measured in Part D Medicare data. The dataset, called PaPR (Providers and Prescribing ... faxes or paper. The PaPR (pronounced "paper") data set aggregates this information ...
Breaking Medicine News(10 mins):